Dr. Grit Andersen invites you to an exclusive live online seminar on the "Initiative Germany as a Location for Clinical Trials (Initiative Studienstandort Deutschland)". Discover current trends and strategic goals aimed at shaping the future of clinical research in Germany. Register now. https://hubs.ly/Q02Fmqq10
Profil Institut für Stoffwechselforschung GmbH
Forschung
We are the leading institute for early phase diabetes clinical trials.
Info
Profil Neuss GmbH is a full service CRO based in Germany and certified according to ISO 9001 and 13485. Profil was founded in 1999 as a spin-off of an academic study group at the department of metabolic diseases and nutrition at University of Düsseldorf. Unlike other CROs, we focus our clinical research on diabetes and related diseases. Because of our professional setup with a huge recruitment database (>13,000 people with diabetes), a dedicated regulatory department, a fully GMP certified pharmacy and two in-house clinics (in Neuss and Mainz) with a total of 80 beds we are able to reliably perform clinical studies within agreed timelines. We have implemented numerous sophisticated methods allowing characterization of pharmacodynamic effects already in early phase trials. Our key competence comprises the performance of glucose clamp studies often combined with isotope dilution techniques and muscle or fat biopsies. We have been involved in the development of all major anti-diabetic compounds. But we are much more than a conventional CRO. We offer a unique combination of regulatory and scientific know-how and expertise. Our portfolio of complex experimental methods is unrivalled within both contract and academic research. Our scientific experts are internationally acknowledged for their contributions in the fields of diabetes, pharmacology, obesity, prediabetes, cardiology, nutrition, endocrinology and medical technology. We have published more than 360 papers in peer-reviewed journals and regularly present our research at international scientific meetings. With our scientific expertise we optimise the design of a study and select the right combination of research methods. The results of our clinical studies deliver the answers needed for the further development of a compound. For more information about Profil, please visit www.profil.com.
- Website
-
http://www.profil.com
Externer Link zu Profil Institut für Stoffwechselforschung GmbH
- Branche
- Forschung
- Größe
- 201–500 Beschäftigte
- Hauptsitz
- Neuss
- Art
- Privatunternehmen
- Gegründet
- 1999
- Spezialgebiete
- Clinical research, Regulatory, Scientific Services, Diabetes, Obesity, Execution of phase I-II, Automated glucose clamps, Clinical data management, Study & protocol design, Recruitment database for subject populations, Statistical analysis und PK/PD modelling
Orte
-
Primär
Hellersbergstr. 9
Neuss, 41460, DE
Beschäftigte von Profil Institut für Stoffwechselforschung GmbH
Updates
-
Meet Dr. Tim Heise, Profil’s Co-Founder and Lead Scientist, at poster 818-P in the poster hall and learn about the effects of Insulin Efsitora Alfa.
-
-
84th American Diabetes Association Scientific session has started! Meet us at booth #507 to discuss your next clinical trial.
-
-
Join Dr. Grit Andersen for an exclusive live online seminar on the "Initiative Germany as a Location for Clinical Trials" to explore current trends and strategic goals to shape the future of clinical research in Germany. Register now.
Online Seminar live - Initiative Germany as a Study Location
info.profil.com
-
Profil, the leading full-service CRO for early phase clinical trials in metabolic disorders, will be attending this year's ADA Scientific Sessions in Orlando. Don't miss the opportunity to meet and discuss with renowned experts Dr. Tim Heise , Dr. J.H. (Hans) de Vries, and Dr. Grit Andersen. Find us at booth #507!
-
-
The first three days of the BIO International Convention have been fantastic! Don't miss the chance to visit us on the last day at booth #4315-04 in the German Pavilion. We look forward to connecting with you!
-
-
Unlock biotech success! Find out how European biotech SMEs turn ideas into market-ready therapies with the help of CROs like Profil. Read about the strategic partnerships that drive innovation and global impact. Don't miss out!
Accelerating Innovation: The Impact of CROs on European Biotech SMEs
blog.profil.com
-
Unlock innovative solutions in #metabolic research: Meet Dr. Lars Bochmann, Profil's Executive Director Commercial Operations, at the upcoming BIO International Convention to benefit from cutting-edge expertise and advance your projects. Find him at Booth 4315-04 at the German Pavilion.
-
-
BIO International Convention here we come! Meet Anshul Sharma in San Diego to discuss your next clinical trial. Visit us at Booth 4315-04 at the German Pavilion. #metabolic #disorders #obesity #MASH #diabetes #CRO
-
-
Navigating Financial Incentives for SMEs in Europe's Biotech Landscape Discover how Europe's support framework for SMEs in obesity and diabetes research is helping to overcome financial barriers and accelerate clinical development. With significant fee reductions and expert guidance from CROs like Profil, SMEs can increase their market readiness and credibility. Learn more about how to leverage these opportunities for success in our latest blog post written by Dr. Lars Bochmann, Executive Director Commercial Operations at Profil. #Biotech #SMEs #HealthcareInnovation #clinicaltrials #cro
Navigating Financial Incentives for SMEs in Europe's Biotech Landscape
blog.profil.com